






To the Editor: Control of com-
municable diseases often relies in part 
on school and workplace exclusion. 
Exclusion policies are also likely to 
play a role in pandemic inﬂ  uenza con-
trol and currently are used as policy 
for control of several vaccine-prevent-
able diseases, including mumps (1). 
Mumps virus is typically present in sa-
liva from 2–3 days before to 4–5 days 
after onset of parotitis. However, virus 
has been isolated from saliva as early 
as 6 days before and as late as 9 days 
after the ﬁ  rst signs of salivary gland 
involvement (2).
In Illinois, persons with mumps 
are excluded from school and the 
workplace for 9 days after onset of 
parotitis (3) to reduce transmission of 
mumps virus. However, exclusion pol-
icy is not consistent among all states. 
For example, persons diagnosed with 
mumps in Iowa are excluded from 
school and the workplace for 5 days, 
whereas persons with mumps in New 
York and California are excluded for 
9 days.
Illinois experienced a mumps out-
break during 2006 that resulted in 796 
cases. We describe a telephone survey 
administered during April–June 2006, 
to a convenience sample of 174 per-
sons >9 days after onset of parotitis 
during this outbreak to assess com-
pliance with school and workplace 
exclusion requirements. The survey 
response rate was 68% (174/257).
Among 94 (54%) persons with 
mumps who had attended school, 85 
(93%) of 91 spent time at home after 
they began experiencing parotitis, and 
6 (7%) of 91 did not stay home from 
school. Most persons were told by lo-
cal health department staff, student 
health services staff, or their medical 
provider to remain at home for 9 days. 
Among persons with mumps who 
spent some time away from school, 
48 (56%) of 85 remained at home for 
>9 days. However, 37 (44%) of 85 
persons did not remain at home for 
the entire exclusion period (median 
5 days; range 1–8 days). Among 111 
(64%) persons who worked outside 
the home, 93 (87%) of 107 spent time 
at home after they began experiencing 
parotitis. 
Among persons who spent time 
away from work, 53 (57%) of 93 re-
mained at home for >9 days. However, 
many persons (41%, 38/93) remained 
at home for fewer than the 9 days re-
quired by the state (median 5 days, 
range 1–8 days) after onset of paroti-
tis. Reasons for complete noncom-
pliance (not remaining at home from 
work during any part of the exclusion 
period) included not feeling ill enough 
to remain at home (50%, 7/14) and not 
receiving a diagnosis until after the 
exclusion period had elapsed (36%, 
5/14) (Table). Because almost 80% of 
these noncompliant persons acknowl-
edged being told not to work, lack of 
such instruction did not play a major 
role in this subset of cases.
Despite public health control mea-
sures, including expanded vaccination 
recommendations (4) and school and 
workplace exclusion, mumps cases in 
Illinois increased 90% from 419 dur-
ing January 1, 2006, through May 17, 
2006, to 796 through December 31, 
2006. Given limited resources of local 
health departments, monitoring and 
ensuring compliance with exclusion 
control measures are likely to be a 
barrier in control of mumps, and these 
difﬁ  culties should be recognized as a 
potential issue in pandemic inﬂ  uenza 
planning. Additional studies targeting 
reasons for failure to comply and how 
to improve compliance will be useful 
preparedness activities.
An examination of whether ex-
clusion for 9 days rather than only 5 
days is a more effective mumps trans-
mission control measure is also need-
ed, given the difﬁ  culty with ensuring 
complete compliance for the full 9 
days. Evidence for 9 days of shedding 
of mumps virus was based on a small 
number of experimentally infected 
children (N = 15), 8 of whom were 
asymptomatic (2). However, mumps 
exclusion policy states that 9 days is 
needed for persons with symptoms of 
parotitis. In addition, the population 
studied included no specimens from 
adults, although the exclusion policy 
derived from these data applies to 
persons of all ages. Finally, exclusion 
policy based only on parotitis may be 
feasible but would not affect persons 
with subclinical and nonspeciﬁ  c clini-
cal infections who may shed mumps 
virus. A uniform evidence-based pol-
icy for exclusion is needed.
Acknowledgments
We thank Kae Hunt for provision of 
mumps surveillance data.
This study was supported in part 
by Centers for Disease Control and Pre-
vention/Council of State and Territorial 
Epidemiologists Cooperative Agreement 
U60/CCU007277.
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 10, October 2007  1617 
Table. Reasons reported by 14 persons with mumps for not remaining home from work 
for any part of the exclusion period 
Reason Frequency,* no. (%) 
Did not feel ill enough to miss work  7 (50) 
Did not receive mumps diagnosis until after exclusion period  5 (36) 
Was not told to remain at home  3 (21) 
Could not financially afford to miss work  2 (14) 
Too busy to miss work  1 (7) 
No sick leave available  1 (7) 
*Some persons reported >1 reason for not remaining home from work. LETTERS
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To the Editor: Alveolar echi-
nococcosis (AE), a serious zoonosis 
caused by the tapeworm Echinococ-
cus multilocularis, has been reported 
in neighboring countries of Lithu-
ania in recent years (1–4), but no 
published epidemiologic informa-
tion is available. The red fox (Vulpes 
vulpes), the main deﬁ  nitive host of 
E. multilocularis in Europe (1), and 
important intermediate rodent hosts 
(e.g.  Arvicola terrestris, Microtus 
arvalis) are present in Lithuania (5), 
but to date they have not been inves-
tigated systematically. The helminth 
fauna of carnivores in Lithuania had 
been investigated in a study in 1976, 
but no record was made for E. multi-
locularis (6). Notably, E. multilocu-
laris has recently been identiﬁ  ed in 
1 of 5 muskrats (Ondatra zibethicus) 
captured in the Šilutė district of Lith-
uania (7). The objectives of our study 
were to estimate the prevalence of E. 
multilocularis in deﬁ  nitive hosts and 
to gather ﬁ  rst information concerning 
AE in humans in Lithuania. 
From 1997 to July 2006, 80 AE 
cases have been diagnosed at the ref-
erence hospital for AE, the Hospital of 
Tuberculosis and Infectious Diseases 
in cooperation with the Santariškių 
Clinic, Vilnius University. Diagno-
ses were based on serologic testing 
using ELISA (Bordier Afﬁ  nity, Cris-
sier, Switzerland) and Western blot 
(LDBIO, Lyon, France) or imaging 
methods (ultrasound scan, computed 
tomography). In 6.7% of the cases 
identiﬁ   ed by imaging techniques, 
serum antibodies were not detected 
by ELISA. Diagnoses in all cases 
were conﬁ   rmed by histopathologic 
examination or typical liver lesion 
morphologic features. Most of the 
cases were registered in the past 5 
years (10–16 cases/year in 2002–July 
2006 compared with 0–4 cases/year 
in 1997–2001). In 26 (33%) of 80 
patients, metacestodes were found in 
the bilateral liver lobes; in 20 (25%) 
metacestodes were found in the right 
lobe. Metacestodes had also spread 
into extra hepatic tissues and metas-
tasized to the right lung, right kidney, 
spleen, and genitals in 18 (23%) of 
the patients. AE was diagnosed in 62 
(78%) of patients in the third to fourth 
clinical stage of the disease, accord-
ing to the PNM (P, parasitic mass in 
the liver; N, involvement of neigh-
boring organs; M, metastasis) classi-
ﬁ  cation: P2-3N0-1M0, P4N1M1 (8); 
twelve (15%) patients died, 7 of them 
within 4–24 months after diagnosis. 
The patients’ ages varied from 21 to 
83 years (mean age 58 years). Women 
were more frequently infected (63%) 
than men (38%), which could be ex-
plained by women’s more frequent 
involvement in gardening. Eighty-one 
percent of AE patients were farmers 
or persons involved in agricultural ac-
tivities. Most AE patients originated 
in the northwestern and northeastern 
parts of Lithuania, but cases were re-
corded from many parts of the coun-
try (Figure), which suggests that the 
whole territory of Lithuania should be 
considered as an AE-endemic area. 
To assess the prevalence of E. 
multilocularis in deﬁ  nitive hosts, the 
small intestines of 206 hunted red 
foxes were collected from randomly 
selected districts from October 2001 
to April 2004 and examined following 
strict safety precautions by the sedi-
mentation and counting technique. 
E. multilocularis was detected in 118 
red foxes (57.3%, 95% conﬁ  dence in-
terval [CI] 50.2%–64.1%). The tape-
worm was present in foxes from most 
tested localities; the highest preva-
lence of 62.3% (CI 49.0–74.4%) was 
observed in the Kaunas district (Fig-
ure). The median worm burden per 
infected fox was 56 (1–20, 924) in 
this district. The high prevalences of 
E. multilocularis in foxes in the exam-
ined areas support the hypothesis that 
foxes play the key role as deﬁ  nitive 
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Letters
Letters commenting on recent articles 
as well as letters reporting cases, out-
breaks, or original research are wel-
come. Letters commenting on articles 
should contain no more than 300 
words and 5 references; they are more 
likely to be published if submitted 
within 4 weeks of the original article’s 
publication. Letters reporting cases, 
outbreaks, or original research should 
contain no more than 800 words and 
10 references. They may have one 
Figure or Table and should not be di-
vided into sections. All letters should 
contain material not previously pub-
lished and include a word count.